Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

被引：3
|
作者：
Deeg, H. Joachim [1 ]
Scott, Bart Lee [1 ,2 ]
Appelbaum, Frederick R. [1 ]
Gooley, Ted [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.666.666
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [41] ABO incompatibility has no effect on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT)
    Sakellari, I
    Stavroylanni, N
    Kalogiannidis, P
    Marantidou, M
    Ganidou, M
    Natse, T
    Batsis, I
    Anagnostopoulos, A
    Fassas, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S115 - S115
  • [42] Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
    Carlos Jiménez-Vicente
    Jordi Esteve
    Mónica Baile-González
    Estefanía Pérez-López
    Carmen Martin Calvo
    Clara Aparicio
    Itziar Oiartzabal Ormategi
    Albert Esquirol
    Felipe Peña-Muñoz
    Sara Fernández-Luis
    Inmaculada Heras Fernando
    Ana Pilar González-Rodríguez
    Alberto López-García
    Jose Luis López-Lorenzo
    Tamara Torrado
    Adolfo Jesús Sáez Marín
    Cynthia Acosta Fleytas
    Lucía García
    Sara Villar
    Silvia Filaferro
    Pascual Balsalobre
    María Jesús Pascual Cascón
    María Queralt Salas
    Blood Cancer Journal, 15 (1)
  • [43] Risk Factors and Impact of Neurological Complications after Allogeneic Hematopoietic Stem Cell Transplantation
    Dowling, Mark R.
    Li, Shuli
    Bhatia, Ashmeet
    El-Jawahri, Areej
    Dey, Bimal R.
    McAfee, Steven L.
    Hock, Hanno
    Spitzer, Thomas R.
    Chen, Yi-Bin
    Ballen, Karen K.
    BLOOD, 2016, 128 (22)
  • [44] Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
    M R Dowling
    S Li
    B R Dey
    S L McAfee
    H R Hock
    T R Spitzer
    Y-B Chen
    K K Ballen
    Bone Marrow Transplantation, 2018, 53 : 199 - 206
  • [45] Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
    Dowling, M. R.
    Li, S.
    Dey, B. R.
    McAfee, S. L.
    Hock, H. R.
    Spitzer, T. R.
    Chen, Y-B
    Ballen, K. K.
    BONE MARROW TRANSPLANTATION, 2018, 53 (02) : 199 - 206
  • [46] Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation
    Sagou, Ken
    Ozeki, Kazutaka
    Ukai, Shun
    Adachi, Yoshitaka
    Fukushima, Nobuaki
    Kohno, Akio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2287 - 2296
  • [47] INDIVIDUAL OUTCOME PREDICTION FOR MDS AND SECONDARY AML AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION BASED ON GENETIC, PATIENT- AND TRANSPLANTATION-ASSOCIATED RISK FACTORS
    Heuser, M.
    Gabdoulline, R.
    Loeffeld, P.
    Dobbernack, V.
    Kreimeyer, H.
    Pankratz, M.
    Flintrop, M.
    Panagiota, V.
    Stadler, M.
    Wichmann, M.
    Shaswar, R.
    Platzbecker, U.
    Thiede, C.
    Schroeder, T.
    Kobbe, G.
    Geffers, R.
    Schlegelberger, B.
    Goehring, G.
    Kreipe, H. -H.
    Germing, U.
    Ganser, A.
    Kroeger, N.
    Koenecke, C.
    Thol, F.
    HAEMATOLOGICA, 2017, 102 : 187 - 187
  • [48] IMPACT OF VITAMIN D LEVEL ON OUTCOME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDHOOD
    Gruhn, Bernd
    Wittig, Susan
    Schneider, Helen
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 571 - 572
  • [49] Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome
    Lin, Ting-An
    Gau, Jyh-Pyng
    Liu, Yao-Chung
    Ko, Po-Shen
    Wang, Hao-Yuan
    Chien, Sheng-Hsuan
    Liu, Chia-Jen
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 584 - 592
  • [50] Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome
    Ting-An Lin
    Jyh-Pyng Gau
    Yao-Chung Liu
    Po-Shen Ko
    Hao-Yuan Wang
    Sheng-Hsuan Chien
    Chia-Jen Liu
    Liang-Tsai Hsiao
    Tzeon-Jye Chiou
    Jin-Hwang Liu
    International Journal of Hematology, 2019, 109 : 584 - 592
12345